Press release
Global Malaria Diagnostics Market is set to witness a decent CAGR of 6% from 2021 to 2026 - Leading Market Players are Access Bio, Abbott, Premier Medical Corporation, Bio-Rad Laboratories, Sysmex Partec GmbH, bioMérieux
Development Of Novel Technologies for Malaria Diagnosis to Fuel the Growth of Malaria Diagnostics Market
The malaria diagnostics market is significantly influenced by technological advancements and development of novel diagnostic tests. Such advances in technology offer numerous advantages to patients and healthcare practitioners by providing better access to high-quality diagnosis at affordable prices, especially in remote areas. Some of the recent developments are listed below:
• In July 2022, Mylab Discovery Solutions launched a comprehensive multiplex RT-PCR kit- PathoDetect Extended Monsoon Fever Panel, for the detection and differentiation between malaria, dengue, Chikungunya, Zika, Salmonellosis bacterial species, Leptospirosis, and Leishmaniasis parasites.
• In February 2022, Kenya's Ministry of Health launched malaria and COVID-19 PCR diagnostic kits to aid timely diagnosis and treatment of these diseases. PlamoCheck malaria diagnostic kit and KEMCoV PCR COVID-19 testing kit are developed locally and are affordable to patients as compared to the imported ones.
• In October 2021, Sysmex introduced its XN-30 research use only (RUO) Automated Hematology Analyzer for the detection of malaria. The automated analyzer features a violet laser and advanced algorithm to determine the level of parasitemia in an EDTA sample.
Explore Detailed Research Insights on Malaria Diagnostics Market @ https://meditechinsights.com/malaria-diagnostics-market/
Initiatives by Government Bodies and Private Institutes to boost adoption of Malaria Diagnostics Market
The global malaria diagnostics market has witnessed a number of initiatives by government bodies and private institutes to either boost the adoption of these tests or to co-develop advanced diagnostic tests. For instance, the US government donated over 1.7 million RDTs for malaria detection and 1.3 million courses of further treatment. Some of the other initiatives are listed below:
• In May 2022, the Global Fund, UnitAid, and the US government along with other partners launched over $120 million support to test-and-treat programs across countries, to provide access to COVID-19 testing and treatment, protect frontline health workers, and reduce COVID-19's negative effects on initiatives to fight HIV, TB, and malaria.
• In October 2021, a five-year strategy 'End Malaria Faster' was released by the US President's Malaria Initiative (PMI), led by the United States Agency for International Development (USAID), that aims to end malaria, address health equities, and improve disease surveillance.
• In January 2019, Abbott Laboratories supported a partnership between Malaria No More, a non-profit organization and the Odisha state government (India) by supplying 1 million RTDs for malaria detection and surveillance as well as provided technical expertise and funding support of $750,000 for a period of three years.
Competitive Landscape Analysis: Malaria Diagnostics Market
The malaria diagnostics market is marked by the presence of key market players such as Access Bio, Inc. (US); Abbott Laboratories (US); Premier Medical Corporation (US); Bio-Rad Laboratories, Inc. (US); Sysmex Partec GmbH (Germany); and bioMérieux (France); and others.
Get a Customized Research Report on Malaria Diagnostics Market @ https://meditechinsights.com/malaria-diagnostics-market/
Ruta Halde
Associate, Medi-Tech Insights
+32 498 86 80 79
info@meditechinsights.com
https://meditechinsights.com/
Medi-Tech Insights is a healthcare-focused business research & insights firm. Our clients include Fortune 500 companies, blue-chip investors & hyper-growth start-ups. We have successfully completed 100+ projects in Digital Health, Healthcare IT, Medical Technology, Medical Devices & Pharma Services.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Global Malaria Diagnostics Market is set to witness a decent CAGR of 6% from 2021 to 2026 - Leading Market Players are Access Bio, Abbott, Premier Medical Corporation, Bio-Rad Laboratories, Sysmex Partec GmbH, bioMérieux here
News-ID: 2697023 • Views: …
More Releases from Medi-Tech Insights
Sterilization Equipment Market Shows Strong Investment Potential with 7-9% CAGR …
The global sterilization equipment market is set to experience significant growth, with an expected CAGR of 7-9% over the next 5 years. This growth is driven by increasing demand for sterilization in healthcare facilities, stringent infection control regulations, rising surgical procedures, necessity to curb hospital-acquired infections (HAIs), and advancements in sterilization technologies.
Sterilization equipment plays a critical role in ensuring the safety and hygiene of medical instruments, devices, and environments. These…
Global Biologics Market Set to Expand at 10-12% CAGR from 2024 to 2029: Medi-Tec …
The global biologics market is set to witness a growth rate of 10-12% in the next 5 years. Rising prevalence of chronic diseases; continued advancements in biotechnology; growing investment in biopharmaceutical R&D; and growing strategic partnerships between biotech firms & larger pharmaceutical companies are some of the key factors driving the biologics market.
Biologics are a class of medications derived from living organisms, including proteins, sugars, and nucleic acids among others.…
Telemedicine Market to Grow at 16-18% CAGR By 2029, Fueled by Tech Advancements …
The global telemedicine market is set to witness a robust growth rate of 16-18% over the next five years. This growth is driven by the increasing adoption of digital healthcare solutions, a rise in chronic disease prevalence, an aging population demanding more accessible care, technological advancements in telehealth platforms, growing government support, and the shift toward remote patient monitoring and virtual care solutions.
Telemedicine refers to the remote diagnosis, treatment, and…
High Flow Oxygen Therapy Market Set to Grow at 7% CAGR by 2029 Driven by Rising …
The high flow oxygen therapy (HFOT) market is growing at a projected compound annual growth rate (CAGR) of around 7% in the forecast period. Key drivers include the rising prevalence of respiratory diseases such as COPD, pneumonia, and acute respiratory failure, along with increased adoption of non-invasive treatments. Technological advancements in HFOT devices and the growing elderly population further support market growth. However, high device costs and limited reimbursement in…
More Releases for Malaria
Industry Dynamics of Cerebral Malaria Therapeutics
Global Cerebral Malaria Therapeutics Market: Overview
Cerebral malaria, a severe neuropathological complication, primarily caused by Plasmodium falciparum. The infectious disease has become prevalent in tropical and sub-tropical countries. The cerebral malaria therapeutics market has evolved on the back of increased understanding of pathogenesis of the neurological syndrome. A growing array of biomarkers and tool in recent years have helped underpin the growing revenue potential in the market, giving rise to numerous…
Malaria Vaccines – Paving the Way for a Malaria-free World
Recent Study on “Malaria Vaccines Market - Global Industry Insights, Trends, Outlook, and Opportunity Analysis and Forecast, 2018-2026” Added to Coherent Market Insights Reports Database.
Malaria Vaccines Market report 2018-2026 focuses on the major drivers and restraints for the key players. These research report also provides granular analysis of the market share, segmentation, revenue forecasts and geographic regions of the market. The Malaria Vaccines market research report is a professional…
Malaria Disease Drug Pipeline Analysis
“Malaria Disease Drug Pipeline Analysis” by PNS Pharma gives comprehensive insight on the various drug profiles being developed for the treatment of Malaria. Research report covers all the ongoing drug development in various phases. Each drug profiles include detailed information like: Originator, Owner, Collaborator, Technology Provider, Licensee, Development Phase, Development Indications, Mechanism of Action, Chemical Formula, Country of Development and detailed analysis on the development process. Insight for each drug…
Rising Prevalence of Cerebral Malaria and Increasing Novel Drug Treatment Drives …
Malaria is a mosquito-borne infectious disease affecting humans and animals caused by parasitic protozoan belonging to the plasmodium family. Malaria is typically transmitted from human to human through the bite of an infected Anopheles (female) mosquito. Symptoms of malaria include fever, headache, fatigue, muscle pain, diarrhea, anemia, and vomiting. Severe malaria can cause yellow skin, seizures, coma, or death. Cerebral malaria is a form of severe malaria. Cerebral malaria has…
Rising Prevalence of Cerebral Malaria and Increasing Novel Drug Treatment Drives …
Malaria is a mosquito-borne infectious disease affecting humans and animals caused by parasitic protozoan belonging to the plasmodium family. Malaria is typically transmitted from human to human through the bite of an infected Anopheles (female) mosquito. Symptoms of malaria include fever, headache, fatigue, muscle pain, diarrhea, anemia, and vomiting. Severe malaria can cause yellow skin, seizures, coma, or death. Cerebral malaria is a form of severe malaria. Cerebral malaria has…
Malaria Diagnostics Market : Future Growth Potential Of The Malaria Diagnostic & …
Malaria is caused by the Plasmodium parasite, which is transmitted by the female Anopheles mosquito. As per the WHO, there were around 203 mn cases of malaria worldwide in 2012, resulting in approximately 627,000 deaths. The diagnosis of malaria involves detection with the help of blood tests and microscopy. Early and accurate diagnosis of malaria is vital for the rapid recovery of the patient and this has raised investments in…
